Raymond James & Associates’s CapForce IBD 50 ETF FFTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,907
| Closed | -$219K | – | 4007 |
|
|
2024
Q1 | $219K | Sell |
7,907
-2,129
| -21% | -$55.7K | ﹤0.01% | 3569 |
|
|
2023
Q4 | $245K | Sell |
10,036
-6,299
| -39% | -$143K | ﹤0.01% | 3406 |
|
|
2023
Q3 | $366K | Buy |
16,335
+342
| +2% | +$8.26K | ﹤0.01% | 3069 |
|
|
2023
Q2 | $409K | Sell |
15,993
-7,675
| -32% | -$182K | ﹤0.01% | 3055 |
|
|
2023
Q1 | $560K | Buy |
23,668
+8,878
| +60% | +$204K | ﹤0.01% | 2849 |
|
|
2022
Q4 | $323K | Sell |
14,790
-21,315
| -59% | -$526K | ﹤0.01% | 3172 |
|
|
2022
Q3 | $882K | Sell |
36,105
-33,017
| -48% | -$914K | ﹤0.01% | 2480 |
|
|
2022
Q2 | $1.86M | Sell |
69,122
-15,926
| -19% | -$512K | ﹤0.01% | 2028 |
|
|
2022
Q1 | $3.33M | Sell |
85,048
-17,391
| -17% | -$675K | ﹤0.01% | 1791 |
|
|
2021
Q4 | $4.7M | Sell |
102,439
-3,981
| -4% | -$190K | ﹤0.01% | 1592 |
|
|
2021
Q3 | $5.04M | Buy |
106,420
+10,051
| +10% | +$470K | ﹤0.01% | 1489 |
|
|
2021
Q2 | $4.47M | Sell |
96,369
-348
| -0.4% | -$15.8K | ﹤0.01% | 1558 |
|
|
2021
Q1 | $4.24M | Buy |
96,717
+3,666
| +4% | +$166K | ﹤0.01% | 1526 |
|
|
2020
Q4 | $3.82M | Buy |
93,051
+13,259
| +17% | +$517K | ﹤0.01% | 1486 |
|
|
2020
Q3 | $2.98M | Buy |
79,792
+3,969
| +5% | +$146K | ﹤0.01% | 1514 |
|
|
2020
Q2 | $2.61M | Sell |
75,823
-13,607
| -15% | -$423K | ﹤0.01% | 1566 |
|
|
2020
Q1 | $2.5M | Sell |
89,430
-136,592
| -60% | -$4.55M | ﹤0.01% | 1445 |
|
|
2019
Q4 | $7.85M | Sell |
226,022
-80,169
| -26% | -$2.71M | 0.01% | 1001 |
|
|
2019
Q3 | $9.88M | Buy |
306,191
+20,066
| +7% | +$686K | 0.01% | 872 |
|
|
2019
Q2 | $9.81M | Buy |
286,125
+13,960
| +5% | +$470K | 0.01% | 868 |
|
|
2019
Q1 | $9.12M | Buy |
272,165
+108,091
| +66% | +$3.4M | 0.01% | 870 |
|
|
2018
Q4 | $4.53M | Sell |
164,074
-79,959
| -33% | -$2.48M | 0.01% | 1160 |
|
|
2018
Q3 | $9.38M | Buy |
244,033
+66,546
| +37% | +$2.45M | 0.01% | 861 |
|
|
2018
Q2 | $6.23M | Buy |
177,487
+118,158
| +199% | +$4.12M | 0.01% | 1060 |
|
|
2018
Q1 | $1.98M | Buy |
59,329
+40,736
| +219% | +$1.39M | ﹤0.01% | 1714 |
|
|
2017
Q4 | $617K | Buy |
+18,593
| New | +$618K | ﹤0.01% | 2409 |
|
|
2017
Q1 | – | Sell |
-10,377
| Closed | -$251K | – | 3329 |
|
|
2016
Q4 | $251K | Buy |
10,377
+52
| +0.5% | +$1.22K | ﹤0.01% | 2757 |
|
|
2016
Q3 | $243K | Sell |
10,325
-255
| -2% | -$5.86K | ﹤0.01% | 2752 |
|
|
2016
Q2 | $227K | Sell |
10,580
-375
| -3% | -$7.9K | ﹤0.01% | 2574 |
|
|
2016
Q1 | $231K | Sell |
10,955
-550
| -5% | -$11.1K | ﹤0.01% | 2495 |
|
|
2015
Q4 | $255K | Buy |
+11,505
| New | +$264K | ﹤0.01% | 2255 |
|
Other funds holding FFTY
IPW
DSCM
CPIG
GVAG
IWM
Raymond James & Associates's FFTY Position: Q2 2024 in Review
Raymond James & Associates sold out of CapForce IBD 50 ETF (FFTY) in Q2 2024, closing a stake of 7,907 shares — an estimated $219K sold.
Raymond James & Associates first reported a position in FFTY in Q4 2015 and held it in 31 quarters. The position peaked at $9.88M in Q3 2019. 36 funds tracked by Wall St. Rank hold FFTY as of Q2 2024.
- Raymond James & Associates reported no remaining CapForce IBD 50 ETF position as of Q2 2024 after selling out during the quarter.
- Raymond James & Associates sold 7,907 CapForce IBD 50 ETF shares in Q2 2024, an estimated $219K.
- Raymond James & Associates first reported a position in CapForce IBD 50 ETF in Q4 2015 and held it in 31 quarters.
- Raymond James & Associates's CapForce IBD 50 ETF position peaked at $9.88M in Q3 2019.
- 36 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2024.
Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.